NCT04782505View on ClinicalTrials.gov

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

March 16, 2021

Study Completion Date

June 28, 2021

Conditions
Healthy
Interventions
DRUG

DWJ1248

Camostat mesylate Tablet from Daewoong

Trial Locations (1)

35015

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY